Taylor Sandison - 31 Mar 2022 Form 4 Insider Report for Cidara Therapeutics, Inc. (CDTX)

Role: Chief Medical Officer
Signature: /s/ Taylor Sandison
Issuer symbol: CDTX
Transactions as of: 31 Mar 2022
Net transactions value: $0
Form type: 4
Filing time: 04 Apr 2022, 17:16:07 UTC
Previous filing: 07 Jan 2022
Next filing: 13 Sep 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CDTX	Common Stock	Award	$0	+50,000	+20%	$0.000000	306,231	31 Mar 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CDTX	Employee Stock Option (right to buy)	Award	$0	+100,000		$0.000000	100,000	31 Mar 2022	Common Stock	100,000	$0.8300	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents time-based Restricted Stock Units (RSUs) granted on March 31, 2022. All RSUs vest in three equal annual installments, with 1/3 vesting on each of March 10, 2023, 2024, and 2025, subject to continuous service through each such vesting date.
F2	The option shall vest and become exercisable in a series of thirty-six (36) successive equal monthly installments measured from the Vesting Commencement Date of March 31, 2022.